- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (1)
- Timeline of Article Publication (4)
- Authors Evaluation (4)
- Article Quality Tracking (1)
- Reference Citation Analysis (5)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3499)
All Articles published online
|
Publishing Process of This Article
|
Jan 6, 2024 (publication date) through May 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu K, Li ZH. Efficacy and safety of Nafamostat mesylate in patients with end-stage renal failure. World J Clin Cases 2024; 12(1): 68-75 [PMID: 38292627 DOI: 10.12998/wjcc.v12.i1.68] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i1/68.htm |
| Number | Citing Articles |
| 1 |
Pei Xie, Huijun Liu, Xingli Huo, Junlong Chen, Yu Li, Yu Huang, Zongning Yin. Nafamostat Mesylate Regulates Glycosylation to Alleviate Aristolochic Acid Induced Kidney Injury. Toxins 2025; 17(3): 145 doi: 10.3390/toxins17030145
|
| 2 |
Mengai Miao, Zhile Chen. Impact of Nafamostat Mesylate Combined with Continuous Renal Replacement Therapy on Clinical Outcomes, Immune Function, and Oxidative Stress Markers in Patients with Sepsis-Associated Acute Kidney Injury. British Journal of Hospital Medicine 2025; 86(2): 1 doi: 10.12968/hmed.2024.0615
|